Clinical trials
Not yet recruiting Phase 2 Cholangiocarcinoma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
18 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2024 | 4 |
| 2025 | 4 |
| 2026 | 10 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Not yet recruiting | 18 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fudan University | 2 |
| Tianjin Medical University Cancer Institute and Hospital | 2 |
| 3D Medicines (Beijing) Co., Ltd. | 1 |
| Eastern Hepatobiliary Surgery Hospital | 1 |
| Federation Francophone de Cancerologie Digestive | 1 |
| GV20 Therapeutics | 1 |
| Harbin Medical University | 1 |
| Incyte Corporation | 1 |
| National Cheng-Kung University Hospital | 1 |
| Shanghai Zhongshan Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cholangiocarcinoma | 18 |
| Biliary Tract Neoplasms | 3 |
| Gallbladder Neoplasms | 2 |
| Bile Duct Neoplasms | 1 |
| Carcinoma | 1 |
| Carcinoma, Non-Small-Cell Lung | 1 |
| Colorectal Neoplasms | 1 |
| Esophageal Squamous Cell Carcinoma | 1 |
| Gastrointestinal Neoplasms | 1 |
| Liver Neoplasms | 1 |
Trials
Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.